Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

RRX

Live52w high -16.6%

Annual Quarterly

Core line items from RRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Annual Quarterly

Entity: REGAL REXNORD CORP·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-08-03	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Annual 2023 2023-12-31	Q3 2023 2023-09-30
Revenue	$1.59B	$3.10B	$1.55B	$6.25B	$4.64B
Operating Income	Not available	$327.80M	$133.90M	$377.10M	$200.10M
Net Income	Not available	$82.30M	$19.80M	$-57.40M	$-113.30M
EPS (Diluted)	$2.61	$1.23	$0.30	$-0.87	$-1.71
Total Assets	Not available	$14.61B	$15.07B	$15.43B	$15.37B
Total Liabilities	Not available	Not available	Not available	Not available	Not available
Cash & Equivalents	Not available	$510.40M	$465.30M	$574.00M	$540.60M
Free Cash Flow OCF − CapEx	Not available	$190.50M	$64.60M	$596.20M	$425.30M
Shares Outstanding	Not available	66.50M	66.50M	66.30M	66.30M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.

Core line items from RRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w high -16.6%

Entity: REGAL REXNORD CORP·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-08-03	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Annual 2023 2023-12-31	Q3 2023 2023-09-30
Revenue	$1.59B	$3.10B	$1.55B	$6.25B	$4.64B
Operating Income	Not available	$327.80M	$133.90M	$377.10M	$200.10M
Net Income	Not available	$82.30M	$19.80M	$-57.40M	$-113.30M
EPS (Diluted)	$2.61	$1.23	$0.30	$-0.87	$-1.71
Total Assets	Not available	$14.61B	$15.07B	$15.43B	$15.37B
Total Liabilities	Not available	Not available	Not available	Not available	Not available
Cash & Equivalents	Not available	$510.40M	$465.30M	$574.00M	$540.60M
Free Cash Flow OCF − CapEx	Not available	$190.50M	$64.60M	$596.20M	$425.30M
Shares Outstanding	Not available	66.50M	66.50M	66.30M	66.30M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.